Ranjbarian, T., Simone, M. D., Antkowiak, M., Sarno, S., Kato, S., Burgoyne, A., Fumagalli, E., Callegaro, D., Fanta, P. T., Gronchi, A., Sicklick, J. K. (2026). Oncologic equivalence of brand-name vs generic imatinib in neoadjuvant
                    <i>KIT</i>
                    exon 11 GIST: A real-world international cohort study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11535